| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/09/2005 | CA2557588A1 Medicaments and methods for treating headache |
| 09/09/2005 | CA2557541A1 Pyrimidine derivatives |
| 09/09/2005 | CA2557489A1 Piperidine derivatives |
| 09/09/2005 | CA2557162A1 Coumarin derivative and use thereof |
| 09/09/2005 | CA2556914A1 Amines and amides for the treatment of diseases |
| 09/09/2005 | CA2556830A1 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber |
| 09/09/2005 | CA2556479A1 Methods and compositions comprising supramolecular constructs |
| 09/09/2005 | CA2556436A1 Process for preparing anit-a.beta. antibody |
| 09/09/2005 | CA2555172A1 Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders |
| 09/09/2005 | CA2546843A1 Compounds and methods for increasing neurogenesis |
| 09/09/2005 | CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 09/09/2005 | CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 09/08/2005 | US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same |
| 09/08/2005 | US20050197380 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 09/08/2005 | US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc. |
| 09/08/2005 | US20050197352 Imidazo-substituted compounds as p38 kinase inhibitors |
| 09/08/2005 | US20050197351 Such as 4-{N-[4-(4-methylbenzenesulfonylamido)benzyl]acetamido}-3-phenyl-2-(piperidine-1-yl)-3,4-dihydroquinazoline; for therapy of angina pectoris, high blood pressure, myocardial disease, pain and epilepsy by blocking the T-type calcium channel |
| 09/08/2005 | US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs |
| 09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/08/2005 | US20050197343 N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide or 2-ferrocenyl compounds; psychiatric diseases: schizophrenia , unipolar depression, disturbances of consciousness, antidepressant; neurodegenerative diseases: Parkinson's disease, attention deficit hyperactivity syndrome; drug abuse |
| 09/08/2005 | US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species |
| 09/08/2005 | US20050197328 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 09/08/2005 | US20050197288 Administering GH-releasing factor (GRF) and analogs (hexenoyl trans-3)hGRF(1-44)NH2 for altering a lipid parameter |
| 09/08/2005 | US20050197286 Method for control of depression using c terminal growth hormone (gh) fragment |
| 09/08/2005 | US20050197284 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease |
| 09/08/2005 | US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing |
| 09/08/2005 | US20050196813 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 09/08/2005 | US20050196802 peptide of given amino acid sequence related to the sulfotransferase drug-metabolizing enzyme subfamily; use drug screening |
| 09/08/2005 | US20050196457 Controlling particle size distribution; preparing a quench liquid;pumping the first phase and the second phase through manifold that includes a plurality of static mixers to form an emulsion; polydispersity |
| 09/08/2005 | US20050196399 antibody capable of specifically recognizing two regions of the A4 peptide/A beta 4, wherein the first region comprises the amino acid sequence AEFRHDSGY and the second region comprises the amino acid sequence YEVHHQKLVFFAEDVG |
| 09/08/2005 | US20050196398 Nucleotide sequences coding specialized hydrolase for use as tool in identifying modulator for prevention and treatment of nervous system disorders; enzyme inhibitors |
| 09/07/2005 | EP1571158A2 Globular assembly of amyloid beta protein and uses thereof |
| 09/07/2005 | EP1571155A1 Peptides and medicinal compositions containing the same |
| 09/07/2005 | EP1571147A2 Pyrazole analogs acting on cannabinoid receptors |
| 09/07/2005 | EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 09/07/2005 | EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists |
| 09/07/2005 | EP1571141A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 09/07/2005 | EP1571140A1 C-substituted cyclohexylmethylamine derivatives |
| 09/07/2005 | EP1570860A1 Antagonist and agonist binding to strong binding site of chemokine receptor |
| 09/07/2005 | EP1570854A1 Drug containing angiotensin convertase |
| 09/07/2005 | EP1570852A2 Xenon for use as drug |
| 09/07/2005 | EP1570848A1 Treating postmenopausal women using ultra-low doses of estrogen |
| 09/07/2005 | EP1570847A1 Phosphodiesterase 10a inhibitors |
| 09/07/2005 | EP1570823A2 Substained analgesia achieved with buprenorphine |
| 09/07/2005 | EP1570052A1 Method for culturing neural stem cells using hepatocyte growth factor |
| 09/07/2005 | EP1569908A2 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
| 09/07/2005 | EP1569905A2 Inhibitors of monoamine uptake |
| 09/07/2005 | EP1569666A1 Herbal preparation for management of cardiovascular and neurologic disorders |
| 09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 09/07/2005 | EP1569638A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 09/07/2005 | EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 09/07/2005 | EP1569636A2 Use of equol for treating androgen mediated diseases |
| 09/07/2005 | EP1569635A1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 09/07/2005 | EP1569627A2 Method of treating movement disorders using barbituric acid derivatives |
| 09/07/2005 | EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 09/07/2005 | EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 09/07/2005 | EP1458717B1 Aroyl pyridinones |
| 09/07/2005 | EP1439829B1 Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient |
| 09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/07/2005 | EP1401839B1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene |
| 09/07/2005 | EP1399434B1 Novel indole derivatives |
| 09/07/2005 | EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/07/2005 | EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 09/07/2005 | EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 09/07/2005 | EP1366039B1 Piperazinylcarbonylquinolines and -isoquinolines |
| 09/07/2005 | EP1349850B1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 09/07/2005 | EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 09/07/2005 | EP1294369B1 NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE |
| 09/07/2005 | EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors |
| 09/07/2005 | EP1188747B1 Phenoxypropylamine compounds |
| 09/07/2005 | EP1178794B1 Use of succinic acid derivatives to obtain a medicine for treating inflammation |
| 09/07/2005 | EP1140026B1 Biodegradble polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 09/07/2005 | EP0731694B2 Opioid formulations for treating pain |
| 09/07/2005 | CN1665929A Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription |
| 09/07/2005 | CN1665828A Novel substituted sulfamate anticonvulsant derivatives |
| 09/07/2005 | CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/07/2005 | CN1665820A Therapeutic or preventive agent for nausea/vomiting |
| 09/07/2005 | CN1665819A Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof |
| 09/07/2005 | CN1665818A N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 09/07/2005 | CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same |
| 09/07/2005 | CN1665812A Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 09/07/2005 | CN1665811A Carbamate-substituted pyrazolopyridines |
| 09/07/2005 | CN1665810A Inhibitors of JAK and CDK2 protein kinases |
| 09/07/2005 | CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/07/2005 | CN1665786A Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 09/07/2005 | CN1665782A Prostaglandin derivatives |
| 09/07/2005 | CN1665780A Tricyclic steroid hormone nuclear receptor modulators |
| 09/07/2005 | CN1665778A Hydroxy tetrahydro-naphthalenylurea derivatives |
| 09/07/2005 | CN1665774A Cinnamide derivatives |
| 09/07/2005 | CN1665538A Phamaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665533A Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 09/07/2005 | CN1665524A Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/07/2005 | CN1665515A Methods for treating psychosis associated with interferon-alpha therapy |
| 09/07/2005 | CN1665512A Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 09/07/2005 | CN1665511A Method of promoting smoking cessation |
| 09/07/2005 | CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases |
| 09/07/2005 | CN1665502A MCHIR antagonists |
| 09/07/2005 | CN1665501A Novel compounds as opioid receptor modulators |
| 09/07/2005 | CN1665497A Use of rotigotine for treating the restless leg syndrome |